Reconfigurable Multi-Organ-on-a-Chip System Reliably Evaluates Chemotherapy Toxicity (3 of 5) (IMAGE)

American Association for the Advancement of Science (AAAS)

Reconfigurable Multi-Organ-on-a-Chip System Reliably Evaluates Chemotherapy Toxicity (3 of 5)

Caption

Hesperos's reconfigurable human-based body-on-a-chip system mimics the way human organs interact with each other and respond to drug testing. This material relates to a paper that appeared in the Jun. 19, 2019, issue of <i>Science Translational Medicine</i>, published by AAAS. The paper, by C.W. McAleer at Hesperos Inc. in Orlando, FL; and colleagues was titled, "Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics."

Credit

[Credit: Hesperos]

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.